Congressionally Directed Medical Research Programs
Overview
The Congressionally Directed Medical Research Programs (CDMRP) are a U.S. Department of Defense program that funds innovative and impactful biomedical research. Established in 1992, the CDMRP is directed by Congress to target specific diseases, conditions, and injuries, with a focus on projects that are high-impact, high-risk, and high-gain that other agencies might not fund. The program supports the full pipeline of research from basic to clinical and aims to find and fund solutions that will lead to cures, improvements in patient care, or breakthrough technologies for Service Members, Veterans, and the American public. The U.S. Army Medical Research and Development Command (USAMRDC) administers the program.
Portfolio Companies
29
Website
cdmrp.health.milInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Rivanna Medical | Oct 2025 | Grant | Lead |
| Vascudyne | Jun 2025 | Grant | Co-investor |
| Sachi Bio | May 2025 | Grant | Co-investor |
| MicroQuin | Feb 2025 | Grant | Lead |
| pacDNA | Jan 2025 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Congressionally Directed Medical Research Programs based?
Congressionally Directed Medical Research Programs is headquartered in Maryland.
When was Congressionally Directed Medical Research Programs founded?
Founding year information for Congressionally Directed Medical Research Programs is not publicly available.
How many portfolio companies does Congressionally Directed Medical Research Programs have?
Congressionally Directed Medical Research Programs has 29 portfolio companies in Caplight's dataset.
What are some companies in Congressionally Directed Medical Research Programs's portfolio?
Recent investments visible on Caplight include Rivanna Medical, Vascudyne, Sachi Bio, MicroQuin, pacDNA.
What was Congressionally Directed Medical Research Programs's most recent investment?
Congressionally Directed Medical Research Programs's most recent investment on Caplight was in Rivanna Medical in 2025.
What sectors does Congressionally Directed Medical Research Programs focus on?
Congressionally Directed Medical Research Programs focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Congressionally Directed Medical Research Programs focus on?
Congressionally Directed Medical Research Programs typically invests at the MultiStage stage.